What is the Role of the FDA in Post-Market Surveillance?
Even after a cancer drug is approved, the FDA continues to monitor its safety and efficacy through post-market surveillance. Manufacturers are required to report adverse events, and the FDA can issue warnings, require additional studies, or even withdraw a drug from the market if new risks are identified.
